PLACIDO HERNANDEZ: Open Payments
NPI 1942463880 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 53 payments from 21 companies in 2025. Trend: 2023 $976 · 2024 $1,227 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| E.R. Squibb & Sons, L.L.C. | 5 | $107 |
| Abbott Laboratories | 3 | $101 |
| Kestra Medical Technology Services, Inc. | 4 | $88 |
| BridgeBio Pharma, Inc. | 3 | $88 |
| Novo Nordisk Inc | 4 | $84 |
| Actelion Pharmaceuticals US, Inc. | 2 | $77 |
| Merck Sharp & Dohme LLC | 4 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
Products named: LEQVIO, CAMZYOS, Assure WCD, Attruby, OPSUMIT, VERQUVO, Kerendia, MERLIN@HOME.
Industry payments across FL — which companies pay providers there.
